Active

STEKENE PHARMA

Switched

BE0473402164

Rechtspersoon Private limited company 1 establishment

Kerkstraat(STE) 64, 9190 Stekene Detailhandel in farmaceutische producten

Active for

25 year, 9 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 265,664

▲ 14% vs 2024

Profit

Growing

€ 51,818

▲ 107% vs 2024

Debts

Low

€ 413,273

▼ 14% vs 2024

STEKENE PHARMA from Stekene, company number BE0473402164, closed financial year 2025 with a result of € 51,818 after tax. For that financial year STEKENE PHARMA recorded a gross margin of € 265,664 and equity of € 485,489. Compared with financial year 2024, the result moved from € 24,984 to € 51,818. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What happened at STEKENE PHARMA?

What happened at STEKENE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 51,818 (▲ 107% vs 2024). Source: NBB ↗
  • Alexo BV became a director. NBB
  • Sodiap BV became a director. NBB
  • New establishment in Stekene. KBO
  • Start of the company according to the CBE. KBO

In short

From € 49,110 profit in 2021 to € 51,818 profit in 2025.

Paid € 36,699 in corporate taxes since 2021.

Best year ever: 2022, with € 51,897 profit.

On average € 156,300 of value added per employee in 2025.

A new publication or filing at STEKENE PHARMA? We notify you, reason included.

Follow STEKENE PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind STEKENE PHARMA are Sodiap BV and Alexo BV. The same people are also behind SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg and Apotheek Seurinck.

See the full network in the app

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE +29 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP +39 more

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkstraat(STE) 64

9190 Stekene

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0473.402.164
VAT number
BE 0473.402.164
Registered office
Kerkstraat(STE) 64, 9190 Stekene
Names & denominations
STEKENE PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 December 2000
Peppol
Active · Active since 6 Jun 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of STEKENE PHARMA?
The enterprise number of STEKENE PHARMA is BE0473402164.
What is the address of STEKENE PHARMA?
The registered office of STEKENE PHARMA is located at Kerkstraat(STE) 64, 9190 Stekene.
When was STEKENE PHARMA founded?
STEKENE PHARMA was founded on 1 December 2000.
What is the main activity of STEKENE PHARMA?
The main activity of STEKENE PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does STEKENE PHARMA have a website?
No website is currently known for STEKENE PHARMA.
How much profit did STEKENE PHARMA make in 2025?
STEKENE PHARMA posted a profit after taxes of € 51,818 in financial year 2025.
What is the revenue of STEKENE PHARMA?
As a small company, STEKENE PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 265,664.
How many employees does STEKENE PHARMA have?
According to the 2025 annual accounts, STEKENE PHARMA has 1.7 full-time equivalents (FTE).
Where can I find the annual accounts of STEKENE PHARMA?
STEKENE PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of STEKENE PHARMA?
According to the 2025 annual accounts, the directors of STEKENE PHARMA are: Sodiap BV, Alexo BV.
Who owns STEKENE PHARMA?
Behind STEKENE PHARMA are Sodiap BV and Alexo BV. The same people are also behind SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg and Apotheek Seurinck.